By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Despite progress in debt reduction and loan resolutions, CMTG's high non-accrual rate (44%) and thin liquidity ($132M) pose significant risks. The potential reinvestment margin squeeze and the uncertainty around pending sales processes further complicate the outlook.
Risk: The concentration of non-accrual loans and the potential reinvestment margin squeeze threaten the company's ability to sustain its dividend and navigate its distressed portfolio.
Opportunity: The successful completion of pending sales processes could provide much-needed liquidity and help CMTG address its non-accrual issues.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Claros Mortgage Trust reported a Q1 2026 GAAP net loss of $0.39 per share, with distributable loss of $0.52 per share. Management said the company remains focused on reducing risk, resolving watchlist assets and lowering leverage.
The company made significant progress on portfolio cleanup, completing about $600 million in loan resolutions during the quarter and seeing held-for-investment loans fall to $3.2 billion from $3.7 billion at year-end. Watchlist loans have also declined substantially over the past year.
Deleveraging continued as Claros refinanced its Term Loan B and cut net debt-to-equity to 1.7x from 1.9x in the prior quarter. The company ended the quarter with $132 million in liquidity and said it hopes to pivot toward offense later in 2026.
Claros Mortgage Trust (NYSE:CMTG) reported a first-quarter loss as management said it continued to focus on reducing risk in its loan book, resolving watchlist assets and lowering leverage.
The company posted a GAAP net loss of $0.39 per share for the first quarter of 2026, while distributable loss was $0.52 per share, President, Chief Financial Officer and Director Mike McGillis said on the earnings call. Distributable loss before realized losses was $0.05 per share.
Chief Executive Officer and Chairman Richard Mack said the company is operating against a backdrop of continued uncertainty in broader financial markets, citing monetary policy, geopolitical events and renewed inflation concerns. Still, Mack said real estate capital markets appear “relatively resilient,” with modestly improved transaction volume compared with a year earlier and tight real estate credit spreads.
“We intend to build on the progress and momentum we established in 2025,” Mack said. He added that the company’s strategic priorities remain focused on turning over the portfolio, resolving watchlist loans, repositioning real estate owned assets and deleveraging the balance sheet.
McGillis said Claros completed approximately $600 million of loan resolutions tied to five investments during the quarter, four of which were watchlist loans. Mack cited $609 million of loan resolutions for the period.
The resolved loans included two regular-way repayments: a $174 million multifamily construction loan in Salt Lake City, which the company originated in 2022, and a $67 million New York City land loan originated in 2019 that had been rated four on the company’s risk scale.
Claros also resolved two five-rated loans during the quarter. A $77 million Dallas multifamily loan was resolved through foreclosure, while a $71 million Seattle office loan was resolved by transferring the company’s rights and interests to the financing counterparty.
The fifth resolution was the March sale of a $220 million loan secured by a luxury hotel property in Northern California. McGillis said the loan had matured in August 2025 and was downgraded to a four risk rating after the company and borrower did not agree on modification terms by year-end 2025. Although management viewed the collateral as “a unique, irreplaceable asset” in a desirable submarket, McGillis said Claros negotiated a quick off-market sale of the loan at 90% of par, which approximated carrying value after general reserves allocated to the loan.
“We view this as a positive and efficient resolution aligned with our strategic priorities,” McGillis said.
After quarter-end, Claros resolved another watchlist loan through foreclosure. The $25 million loan was collateralized by a multifamily property in Dallas and had previously been rated five. McGillis said the company believes it can create more value for shareholders by owning the asset rather than selling the loan.
Watchlist and Non-Accrual Exposure Remain in Focus
Claros’ held-for-investment loan portfolio declined to $3.2 billion as of March 31, from $3.7 billion at Dec. 31. McGillis said hospitality exposure fell to $592 million from $807 million, while land exposure declined to $120 million from $187 million.
Management said the company currently has eight lender-driven sale processes underway across its watchlist loan and REO portfolios. McGillis said those processes could produce additional resolutions of about $861 million, measured by unpaid principal balance for loans and carrying value for REO assets.
During the question-and-answer portion of the call, KBW analyst Jade Rahmani asked about non-accrual loans, which he said totaled $1.55 billion across 11 loans, or roughly 44% of the portfolio. McGillis said it was difficult to provide a precise forecast, but said Claros expected to “continue to chip away” at non-earning and sub-earning assets, use proceeds to repay leverage, reduce interest expense and increase liquidity.
Priyanka Garg, executive vice president of portfolio and asset management, said four of the eight active sale processes involved loans, accounting for about three-quarters of the roughly $860 million total. She said all four loans are on the watchlist and non-accrual, representing “a good chunk” of the non-accrual balance.
Garg said the company’s watchlist loans have declined from $2.7 billion in January 2025 to $1.4 billion. “We’ve demonstrated over five quarters that we’re very committed to bringing that number down,” she said.
Credit Migration Slows, CECL Reserve Declines
McGillis said the pace of credit migration slowed meaningfully in the quarter, with only two loans moving. The company downgraded one $127 million loan collateralized by a portfolio of Texas multifamily assets from a three to a four risk rating, citing the borrower’s unwillingness to invest additional equity ahead of a June 2026 maturity. Claros also placed a $155 million loan secured by a Phoenix multifamily property on non-accrual because of continued delinquency and lack of progress on modification terms.
As of March 31, the portfolio included 13 loans rated four or five, down from 24 such loans a year earlier, McGillis said.
Claros recorded a $31 million provision for current expected credit losses during the quarter. Total CECL reserves on held-for-investment loans decreased to $399 million, or 11.4% of unpaid principal balance, from $443 million, or 10.9% of unpaid principal balance, at Dec. 31. The general CECL reserve declined to $50 million from $78 million.
Debt Refinancing and Deleveraging
In January, Claros retired its existing Term Loan B, which had been scheduled to mature in August 2026, and replaced it with a $500 million senior secured term loan from HPS. McGillis said the new loan carries a four-year term, matures in January 2030, includes prepayment flexibility and is priced at SOFR plus 675 basis points. The company also aligned financial covenants across its financing facilities.
Claros reduced outstanding financings by $489 million during the first quarter, including $142 million of deleveraging payments. Net debt-to-equity fell to 1.7 times at March 31, compared with 1.9 times at Dec. 31 and 2.4 times a year earlier. The company ended the quarter with $132 million in liquidity.
Mack said 2026 will be a year of continued execution as Claros seeks to resolve troubled loans and REO, pay down debt and build cash. He said the company hopes to “pivot to offense” by the end of the year, which could include new originations, further deleveraging, reinvestment in select REO assets or share repurchases.
About Claros Mortgage Trust (NYSE:CMTG)
Claros Mortgage Trust is a specialty finance company structured as a real estate investment trust that acquires and manages a portfolio of newly originated, conventional residential mortgage loans guaranteed or insured by U.S. government‐sponsored enterprises. The company concentrates on Agency collateral, including loans backed by Ginnie Mae, Fannie Mae and Freddie Mac, aiming to generate current income while preserving capital through high‐quality, credit‐enhanced assets.
Under an external management agreement with Claros Mortgage Capital Advisors LLC, the firm leverages a seasoned team to source, underwrite and service mortgage assets.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Four leading AI models discuss this article
"With nearly half the portfolio on non-accrual, CMTG is effectively a runoff vehicle masquerading as a going concern, making any 'pivot to offense' premature until the balance sheet is significantly cleaner."
Claros (CMTG) is in a classic 'liquidation-by-attrition' phase. While management touts deleveraging and a pivot to offense, the 44% non-accrual rate on a $3.2 billion portfolio is a massive anchor. Reducing debt is necessary, but at 1.7x net debt-to-equity, they are still highly levered relative to their impaired asset base. The sale of the Northern California hotel at 90% of par suggests they are willing to take haircuts to exit, which is prudent but earnings-dilutive. With $132 million in liquidity and $861 million in pending resolutions, the focus is purely on survival, not growth. I see no catalyst for a re-rating until the non-accrual ratio drops below 20%.
If real estate capital markets continue to tighten spreads as Mack suggests, the value of their remaining REO assets could recover faster than anticipated, providing a non-dilutive boost to book value.
"CMTG's deleveraging and $600M resolutions materially shrink risk, but 44% non-accruals cap upside until sale processes deliver."
CMTG shows tangible cleanup progress: $600M loan resolutions (incl. $609M cited), held-for-investment portfolio down to $3.2B from $3.7B, watchlist from $2.7B (Jan 2025) to $1.4B, hospitality/land exposure slashed. Deleveraging to 1.7x net debt/equity (from 2.4x YoY), $132M liquidity, refinanced Term Loan B at SOFR+675bps to 2030. But 44% non-accrual ($1.55B/11 loans) remains alarming; CECL reserves at 11.4% UPB. Note: article's description mismatches reality—CMTG is a CRE mREIT, not Agency residential. Eight $861M sale processes underway could unlock value or reveal losses if markets sour.
Despite resolutions, selling troubled assets like the 90%-par hotel loan signals haircuts ahead, and with 44% non-accruals plus slowing credit migration, failed sales or deeper CRE distress (office/hospitality) could balloon provisions beyond the $31M Q1 hit.
"CMTG is swapping visible losses for hidden concentration risk—11 non-accrual loans at $1.55B represent 44% of the portfolio, and thin liquidity ($132M) leaves little margin for error if market conditions deteriorate."
CMTG is executing a credible balance-sheet repair: $600M quarterly resolutions, watchlist loans halved YoY to $1.4B, net leverage down to 1.7x from 2.4x. The $220M hotel loan sale at 90% par is honest—they're not hiding losses. But here's the trap: 44% of the portfolio ($1.55B) is non-accrual across just 11 loans. That concentration risk means a few more downgrades could force asset sales into weak markets. The $31M CECL provision decline masks that they're resolving bad loans, not healing the portfolio. Liquidity at $132M is thin for a $3.2B portfolio. 'Pivot to offense' language is premature—they're still in triage.
If real estate credit spreads remain tight and transaction volume continues improving, CMTG's $861M pending sale processes could clear faster than expected, materially reducing non-accrual exposure and justifying a faster deleveraging path than the market prices in.
"Despite cleanup momentum, Claros’ core book remains materially impaired with high non-accruals and tight liquidity; without rapid, favorable asset resolutions and a stable macro environment, the equity case remains fraught."
Claros’ quarter shows portfolio cleanup progress but underlying credit risk remains large. While watchlist resolutions and de-leveraging improved the balance sheet, the company still carries about $1.55B in non-accruing loans (roughly 44% of the portfolio) and CECL reserves at 11.4% of UPB, signaling meaningful potential impairment. Liquidity is tight at $132M and the new term loan pricing (SOFR + 675 bps) plus a 2030 maturity place ongoing pressure on funding costs. The ‘pivot to offense’ is contingent on continued fragile real estate liquidity and favorable sale outcomes, which remains uncertain amid broader market volatility.
If eight active sale processes deliver substantial proceeds and non-accruals shrink faster than modeled, deleveraging could accelerate and the pivot to offense could materialize sooner, delivering upside. But the magnitude and timing depend on real estate liquidity; renewed market stress could stall this path.
"The 90% par recovery is an outlier, and the company's thin liquidity leaves no margin for error if the remaining $861M in asset sales face market resistance."
Claude, you’re missing the structural trap: the 90% par recovery on that hotel loan is a best-case outlier, not a benchmark. With 11 loans driving 44% of non-accruals, the concentration risk is binary, not probabilistic. If those $861M in pending sales hit a bid-ask wall, the 'triage' becomes a liquidation spiral. The market isn't pricing a pivot; it's pricing a fire sale. Liquidity is the only metric that matters here, and $132M is insufficient for this level of distress.
"Pending sales buffer liquidity but force low-yield reinvestments that erode margins and dividend coverage."
Gemini, fixating on $132M liquidity ignores the $861M pending sales as a dynamic buffer—eight processes could double liquidity in months if spreads hold. But unaddressed second-order risk: resolved non-accruals expose a $3.2B portfolio to reinvestment at current 6-7% CRE yields (down from 8% origination), squeezing net interest margins below 200bps and threatening the 10% dividend sustainability amid repo pressures.
"Portfolio resolution doesn't equal recovery if reinvestment yields have structurally compressed below dividend sustainability thresholds."
Grok's reinvestment-margin squeeze is the real trap nobody's pricing. If $861M in sales clear at 6-7% yields versus 8% origination, NIM compression hits dividend coverage before non-accruals resolve. Gemini's liquidity obsession is valid but misses the timing: $132M survives 12 months if sales stagger. The binary risk isn't liquidity—it's whether resolved loans can be replaced profitably. That's the silent killer.
"Eight-sale liquidity is a fragile buffer; any stall or weaker bids could erode the cushion and force earlier-than-expected NIM compression."
Grok, your liquidity tailwind assumes eight sale processes don't stall and spreads stay generous. If bid-asks reset weaker, those $861M in sales could fall short, and you’d drain liquidity faster than you gain it. More importantly, even with liquidity improving, the reinvestment hurdle—replacing 6-7% CRE yields with 8% origination levels—could compress NIM and threaten dividend coverage before non-accruals fully resolve. The pivot to offense hinges on a fragile, second-order market dynamic.
Despite progress in debt reduction and loan resolutions, CMTG's high non-accrual rate (44%) and thin liquidity ($132M) pose significant risks. The potential reinvestment margin squeeze and the uncertainty around pending sales processes further complicate the outlook.
The successful completion of pending sales processes could provide much-needed liquidity and help CMTG address its non-accrual issues.
The concentration of non-accrual loans and the potential reinvestment margin squeeze threaten the company's ability to sustain its dividend and navigate its distressed portfolio.